DIN 02532557 — CAMZYOS 5 MG
CAMZYOS is a capsule of Mavacamten marketed by BRISTOL-MYERS SQUIBB CANADA. The full Mavacamten monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02532557
- Brand name
- CAMZYOS
- Active ingredient
- Mavacamten
- Strength
- 5 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- BRISTOL-MYERS SQUIBB CANADA
- Health Canada status
- MARKETED
- Drug class
- Cardiac myosin inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Mavacamten products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02532565 | CAMZYOS | 10 MG | CAPSULE | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02532573 | CAMZYOS | 15 MG | CAPSULE | BRISTOL-MYERS SQUIBB CANADA | MARKETED |
| 02532549 | CAMZYOS | 2.5 MG | CAPSULE | BRISTOL-MYERS SQUIBB CANADA | MARKETED |